Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Home Page Research

    Abramson lands breast cancer research award

    Wednesday, July 23rd, 2014

    by Dagny Stuart     Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). The CCF grants and awards support cancer research done by physician-scientists at every stage of their careers. Abramson’s […]

    Research bolstered by lung cancer foundation

    Monday, July 21st, 2014

    by Dagny Stuart The LUNGevity Foundation has awarded a 2014 Career Development Award for Translational Research to Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology. Lovly is one of three recipients of the annual grants, which provide $300,000 over three years for lung cancer research. “This is a wonderful award and I […]

    Breast tissue protein may promote cancer

    Friday, July 18th, 2014

    by Bill Snyder A protein essential for growth of normal breast tissue also may play a role in breast cancer, Vanderbilt University researchers have found. Reporting recently in Nature Cell Biology, Yongliang Huo, Ph.D., and Ian Macara, Ph.D., for the first time describe the function of a protein called Par3L, which is expressed by a […]

    Pietenpol joins IOM Cancer Policy Forum

    Thursday, July 10th, 2014

    by Dagny Stuart Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. The IOM established the forum to serve as a trusted venue for […]

    VICC researchers in national spotlight

    Wednesday, June 25th, 2014

    by Dagny Stuart Early research suggests patients with advanced melanoma — the most deadly form of skin cancer — may benefit from both immunotherapies and targeted therapies aimed at specific gene mutations. However, no combinations of these two classes of drugs have been shown to be safe, so far. The results of the first such […]

    HPV-Positive Head and Neck Cancer Patients May be Safely Treated with Lower Radiation Dose

    Thursday, June 19th, 2014

    by Dagny Stuart A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. The research was presented by lead author Anthony Cmelak, M.D., professor of Radiation Oncology at Vanderbilt-Ingram Cancer Center (VICC), during the 50th annual meeting of […]

    Rising Tobacco Epidemic in Asia

    Tuesday, June 10th, 2014

    A new study estimates that tobacco smoking has been linked to approximately 2 million deaths among adult men and women in Asia in recent years and predicts a rising death toll. The study, published in PLOS Medicine, was led by Wei Zheng, M.D., Ph.D., MPH, professor of Medicine and director of the Vanderbilt Epidemiology Center, […]

    Arteaga Assumes AACR Post

    Tuesday, April 22nd, 2014

    Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center, has assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015. He was inaugurated during the AACR Annual Meeting which was held April 5-9, in San Diego. AACR, founded […]

    NIH Grant Supports Colon Research

    Friday, August 16th, 2013

    Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Most RNA works inside cells to translate genes into proteins that are necessary for organisms to function. Now, recent […]

    Lovly earns Damon Runyon Cancer Research Award

    Wednesday, July 17th, 2013

    Christine Lovly, M.D., Ph.D., instructor in Medicine at the Vanderbilt University School of Medicine, has earned the 2013 Damon Runyon Clinical Investigator Award, which supports young physician-scientists conducting patient-oriented cancer research. The three-year award will provide $450,000 for Lovly’s research efforts in lung cancer. “I am so honored to receive this prestigious and competitive award […]

    Next Page »« Previous Page